New devices to treat leg artery disease

Cook Medical is introducing an integrated line of six new products to provide minimally-invasive treatment options for peripheral arterial disease (PAD). These products,...

Healthcare budgets get personal

'Direct payment' of personal health budgets has moved closer with a new consultation launched by Care Services Minister Phil Hope. Personal health budgets -...

Putting the message across

Siemens Hearing Instruments has extended its range of support initiatives for audiology dispensers in the retail marketplace. Its new schedule of workshops and...

EU approves Merck’s Schering-Plough takeover

The European Union has approved Merck’s proposed takeover of Schering-Plough, which would create the second biggest global producer of prescription medicines. The EU’s antitrust...

Doctors.net.uk launches new research service

A new online market research service for pharmaceutical marketers has been launched by Doctors.net.uk, the largest and most active network of medical professionals in...

Exported device injects life into UK economy

An Oxfordshire-based company that offers needle-free vaccinations has been highlighted by Lord Davies, Minister for Trade, Investment and Small Business, as an example of...

Novo Nordisk to launch insulin pen for children

Novo Nordisk will launch a new insulin pen, designed to meet the needs of children with diabetes, in several countries next year. The NovoPen...

RoActemra launched in UK

Roche has launched its novel biologic RoActemra in the UK, despite a negative opinion from NICE that leaves the drug unavailable on the NHS,...

Mountain Trike rides high at investment showcase

Mountain Trike, the creator of an all-terrain wheelchair, was among 21 start-up companies demonstrating their innovative technologies at the SETsquared Partnership Investment Showcase 2009....

NICE denies NHS access to Tyverb

Tyverb has been rejected by NICE for breast cancer, despite the manufacturer’s efforts to comply with the new guidance on treatments for small patient...

Latest articles

AI-driven chemistry retrosynthesis tool to advance drug discovery

AI-driven chemistry retrosynthesis tool to advance drug discovery

In a bid to help to bring drugs to market for patients most in need, Elsevier, a global research publishing and information analytics provider,...
Image of a robotic hand moving a chess piece to show Lifting the lid on robotic process automation

Lifting the lid on robotic process automation

Today, robotic process automation (RPA) registers strongly on the radar of Regulatory Affairs departments; many companies are talking about it or looking at it,...
Star OUTiCO

Healthcare service providers Star Medical and OUTiCO merge to create new brand identity

Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry and part of the global Uniphar Group, has launched...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Star OUTiCO

Healthcare service providers Star Medical and OUTiCO merge to create new brand identity

Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry and part of the global Uniphar Group, has launched...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
AI-driven chemistry retrosynthesis tool to advance drug discovery

AI-driven chemistry retrosynthesis tool to advance drug discovery

In a bid to help to bring drugs to market for patients most in need, Elsevier, a global research publishing and information analytics provider,...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription